Benchmark Begins Coverage on XOMA (NASDAQ:XOMA)
Equities research analysts at Benchmark began coverage on shares of XOMA (NASDAQ:XOMA – Get Free Report) in a research report issued to clients and investors on Thursday, MarketBeat reports. The brokerage set a “buy” rating and a $35.00 price target on the biotechnology company’s stock. Benchmark’s price target would indicate a potential upside of 65.25% […]
More Stories
Balyasny Asset Management L.P. Invests $318,000 in SiTime Co. (NASDAQ:SITM)
Balyasny Asset Management L.P. purchased a new position in SiTime Co. (NASDAQ:SITM – Free Report) in the fourth quarter, according...
Captrust Financial Advisors Grows Holdings in Encompass Health Co. (NYSE:EHC)
Captrust Financial Advisors grew its holdings in Encompass Health Co. (NYSE:EHC – Free Report) by 71.3% during the fourth quarter,...
JPMorgan Chase & Co. Cuts UnitedHealth Group (NYSE:UNH) Price Target to $405.00
UnitedHealth Group (NYSE:UNH – Free Report) had its price objective reduced by JPMorgan Chase & Co. from $525.00 to $405.00...
Cetera Investment Advisers Has $2.66 Million Stake in Range Resources Co. (NYSE:RRC)
Cetera Investment Advisers raised its position in shares of Range Resources Co. (NYSE:RRC – Free Report) by 2.0% in the...
Amazon.com, Inc. (NASDAQ:AMZN) Shares Sold by Two Sigma Securities LLC
Two Sigma Securities LLC decreased its stake in Amazon.com, Inc. (NASDAQ:AMZN) by 20.8% in the 4th quarter, according to the...
Amazon.com, Inc. (NASDAQ:AMZN) is Cheviot Value Management LLC’s 10th Largest Position
Cheviot Value Management LLC increased its stake in Amazon.com, Inc. (NASDAQ:AMZN) by 1.4% during the 4th quarter, Holdings Channel reports....